https://www.marketscreener.com/quote/stock/ALDEYRA-THERAPEUTICS-INC-16253115/news/Aldeyra-Therapeutics-Announces-First-Patient-Enrolled-in-Allergic-Conjunctivitis-Phase-IIa-Clinical-21113097/?utm_source=telegram&utm_medium=social&utm_campaign=share